Myo-Inositol- Based Co-treatment in Women With PCOS Undergoing Assisted Reproductive Technology

Inclusion Criteria: * Age 18-40 years at the time of enrollment. * Women diagnosed with PCOS according to the Rotterdam criteria indicated by oligoamenorrhea (six or fewer menstrual cycles during a period of 1 year), hyperandrogenism (hirsutism, acne, or alopecia) or hyperandrogenemia (elevated levels of total or free T) and typical features of ovaries on ultrasound scan. * Planned IVF/ICSI treatment. * Normal uterine cavity (as assessed by hysteroscopy or HSG). * Normal hormonal investigation: TSH and PRL. Exclusion Criteria: * Azoospermia. * Other medical conditions causing ovulatory disorders, such as hyperprolactinemia, hypothyroidism, or adrenal hyperplasia. * Hypersensitivity to Myo-Inositol or its derivatives.